• bitcoinBitcoin(BTC)$77,282.00-0.73%
  • ethereumEthereum(ETH)$2,539.160.92%
  • tetherTether(USDT)$1.000.02%
  • binancecoinBNB(BNB)$736.002.07%
  • rippleXRP(XRP)$1.37-0.10%
  • usd-coinUSDC(USDC)$1.000.00%
  • solanaSolana(SOL)$101.890.15%
  • tronTRON(TRX)$0.3403941.28%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.02-1.77%
  • zcashZcash(ZEC)$1,154.12-0.32%
  • HyperliquidHyperliquid(HYPE)$80.28-1.67%
  • dogecoinDogecoin(DOGE)$0.084952-0.18%
  • RainRain(RAIN)$0.015074-5.01%
  • moneroMonero(XMR)$531.144.03%
  • USDSUSDS(USDS)$1.000.00%
  • whitebitWhiteBIT Coin(WBT)$80.37-0.58%
  • chainlinkChainlink(LINK)$11.55-1.43%
  • leo-tokenLEO Token(LEO)$9.12-0.35%
  • cardanoCardano(ADA)$0.2084280.24%
  • stellarStellar(XLM)$0.1811791.35%
  • bitcoin-cashBitcoin Cash(BCH)$230.480.56%
  • Ethena USDeEthena USDe(USDE)$1.000.03%
  • daiDai(DAI)$1.00-0.02%
  • USD1USD1(USD1)$1.000.01%
  • litecoinLitecoin(LTC)$53.880.61%
  • uniswapUniswap(UNI)$6.413.38%
  • CantonCanton(CC)$0.097841-0.10%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.370.57%
  • Global DollarGlobal Dollar(USDG)$1.000.00%
  • avalanche-2Avalanche(AVAX)$7.44-1.32%
  • hedera-hashgraphHedera(HBAR)$0.074580-1.09%
  • shiba-inuShiba Inu(SHIB)$0.0000052.62%
  • nearNEAR Protocol(NEAR)$2.37-9.57%
  • suiSui(SUI)$0.73-1.13%
  • crypto-com-chainCronos(CRO)$0.0582662.78%
  • paypal-usdPayPal USD(PYUSD)$1.000.00%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • MemeCoreMemeCore(M)$1.17-1.63%
  • tether-goldTether Gold(XAUT)$4,347.99-0.93%
  • Circle USYCCircle USYC(USYC)$1.140.00%
  • Ripple USDRipple USD(RLUSD)$1.00-0.01%
  • okbOKB(OKB)$113.920.73%
  • BittensorBittensor(TAO)$234.80-1.84%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.150.04%
  • aaveAave(AAVE)$126.281.04%
  • mantleMantle(MNT)$0.57-2.66%
  • pax-goldPAX Gold(PAXG)$4,353.66-0.91%
  • AsterAster(ASTER)$0.68-1.75%
  • World Liberty FinancialWorld Liberty Financial(WLFI)$0.0569418.00%
  • polkadotPolkadot(DOT)$1.04-3.56%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

MIT Researchers Unveil InfoCORE: A Machine Learning Approach to Overcome Batch Effects in High-Throughput Drug Screening

January 20, 2024
in AI & Technology
Reading Time: 4 mins read
A A
MIT Researchers Unveil InfoCORE: A Machine Learning Approach to Overcome Batch Effects in High-Throughput Drug Screening
ShareShareShareShareShare

Recent studies have shown that representation learning has become an important tool for drug discovery and biological system understanding. It is a fundamental component in the identification of drug mechanisms, the prediction of drug toxicity and activity, and the identification of chemical compounds linked to disease states.

The limitation arises in representing the complex interplay between a small molecule’s chemical structure and its physical or biological characteristics. Several molecular representation learning techniques currently in use solely encode a molecule’s chemical identification, leading to unimodal representations, which has drawbacks as molecules with comparable structures can have remarkably diverse functions within a biological setting.

Recent efforts have concentrated on training models that apply multimodal contrastive learning to map 2D chemical structures to high-content cell microscope pictures. In biotechnology, high-throughput drug screening is essential for assessing and understanding the relationship between a drug’s chemical structure and biological activity. This method uses gene expression measures or cell imaging to indicate drug effects. 

However, handling batch effects presents a major challenge when running large-scale screens, necessitating their division into many trials. The appropriate interpretation of results may be hampered by these batch effects, which can potentially incorporate systematic mistakes and non-biological connections into the data. 

To overcome this, a team of researchers has recently presented InfoCORE, an Information maximization strategy for COnfounder REmoval. Effectively managing batch effects and improving the caliber of molecular representations derived from high-throughput drug screening data are the main goals of InfoCORE. Given a batch identifier, the method sets a variational lower bound on the conditional mutual information of latent representations. It does this by adaptively reweighting samples to equalize their inferred batch distribution.

Extensive tests on drug screening data have shown that InfoCORE performs better than other algorithms on a variety of tasks, such as retrieving molecule-phenotype and predicting chemical properties. This implies that InfoCORE successfully reduces the influence of batch effects, resulting in better performance in tasks pertaining to molecular analysis and drug discovery.

The study has also emphasized on how flexible InfoCORE is as a framework that can handle more complex issues. It has shown how InfoCORE can manage shifts in the general distribution and data fairness problems by reducing correlation with bogus characteristics or eliminating sensitive attributes. InfoCORE’s versatility makes it a powerful tool for tackling a variety of challenges connected to data distribution and fairness, in addition to removing the batch effect in drug screening.

The researchers have summarized their primary contributions as follows.

  1. The InfoCORE approach aims to propose a multimodal molecular representation learning framework that can smoothly integrate chemical structures with a variety of high-content drug screens.
  1. The research provides a strong theoretical foundation by demonstrating that InfoCORE maximizes the variational lower bound on the conditional mutual information of the representation given the batch identifier.
  1. InfoCORE has demonstrated its efficiency in molecular property prediction and molecule-phenotype retrieval tasks by consistently outperforming several baseline models in real-world studies.
  1. InfoCORE’s information maximization philosophy extends beyond the field of drug development. Empirical evidence supports its effectiveness in removing sensitive information for representation fairness, making it a flexible tool with wider uses.

Check out the Paper and Github. All credit for this research goes to the researchers of this project. Also, don’t forget to follow us on Twitter. Join our 36k+ ML SubReddit, 41k+ Facebook Community, Discord Channel, and LinkedIn Group.

If you like our work, you will love our newsletter..

Don’t Forget to join our Telegram Channel


YOU MAY ALSO LIKE

Is A 256GB SSD Better Than A 1TB Hard Drive? It Depends How You’re Using It

What Is Benchmark Saturation? Why Yesterday’s AI Tests Stop Working – Unite.AI

Tanya Malhotra is a final year undergrad from the University of Petroleum & Energy Studies, Dehradun, pursuing BTech in Computer Science Engineering with a specialization in Artificial Intelligence and Machine Learning.
She is a Data Science enthusiast with good analytical and critical thinking, along with an ardent interest in acquiring new skills, leading groups, and managing work in an organized manner.


🐝 Join the Fastest Growing AI Research Newsletter Read by Researchers from Google + NVIDIA + Meta + Stanford + MIT + Microsoft and many others…


Credit: Source link

ShareTweetSendSharePin

Related Posts

Is A 256GB SSD Better Than A 1TB Hard Drive? It Depends How You’re Using It
AI & Technology

Is A 256GB SSD Better Than A 1TB Hard Drive? It Depends How You’re Using It

September 12, 2026
What Is Benchmark Saturation? Why Yesterday’s AI Tests Stop Working – Unite.AI
AI & Technology

What Is Benchmark Saturation? Why Yesterday’s AI Tests Stop Working – Unite.AI

September 12, 2026
Kai-Fu Lee Says China Will Win AI Reach Race
AI & Technology

Kai-Fu Lee Says China Will Win AI Reach Race

September 12, 2026
Everybody’s Business: Unpacking Apple’s Upcoming Launches
AI & Technology

Everybody’s Business: Unpacking Apple’s Upcoming Launches

September 12, 2026
Next Post
The #etf decision helps bring #bitcoin mainstream, says Coinbase CFO #technology #shorts

The #etf decision helps bring #bitcoin mainstream, says Coinbase CFO #technology #shorts

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Reported tornadoes hit New York City area

Reported tornadoes hit New York City area

September 7, 2026
Trump takes questions on Iran and cyclosporiasis outbreak during White House event

Trump takes questions on Iran and cyclosporiasis outbreak during White House event

September 5, 2026
Canoodling lawyers’ firm rocked by another major defection as top attorney bolts

Canoodling lawyers’ firm rocked by another major defection as top attorney bolts

September 10, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!